Some of the non-technological barriers outline India may face are Pharmaceutical companies, and government agencies such as the Drug Administration and the National Institutes of Health.
<u>Step-by-step explanation:</u>
Pharmaceutical companies and government agencies such as the Drug Administration possess large research data.
If these data were shared more extensively, the resulting research taken from data could improve health spur drug development.
Data sharing increases public trust in clinical trials.
Much of this information is never shared.
Retention of clinical research data by organizations leads to lost opportunities in biomedical experiments and research.
Barriers to data sharing include concerns about data pool mining and unwarranted litigation.
